A61P 3/12
Drugs for disorders of the metabolism: for electrolyte homeostasis
Official title: for electrolyte homeostasis
A61P3/12 (Drugs for disorders of the metabolism: for electrolyte homeostasis) appears on 2,270 US grants and 3,098 published applications in this corpus.
Search patents in A61P- Granted patents
- 2,270
- Published applications
- 3,098
- Assignees
- 1,123
- Inventors
- 6,066
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 3 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 2 | 0 |
| 1984 | 4 | 0 |
| 1985 | 12 | 0 |
| 1986 | 10 | 0 |
| 1987 | 19 | 0 |
| 1988 | 24 | 0 |
| 1989 | 20 | 0 |
| 1990 | 27 | 0 |
| 1991 | 15 | 0 |
| 1992 | 15 | 0 |
| 1993 | 9 | 0 |
| 1994 | 21 | 0 |
| 1995 | 15 | 0 |
| 1996 | 20 | 0 |
| 1997 | 32 | 0 |
| 1998 | 34 | 0 |
| 1999 | 32 | 0 |
| 2000 | 42 | 0 |
| 2001 | 46 | 16 |
| 2002 | 52 | 82 |
| 2003 | 51 | 142 |
| 2004 | 53 | 142 |
| 2005 | 47 | 157 |
| 2006 | 64 | 130 |
| 2007 | 64 | 165 |
| 2008 | 69 | 164 |
| 2009 | 78 | 235 |
| 2010 | 128 | 256 |
| 2011 | 121 | 176 |
| 2012 | 126 | 191 |
| 2013 | 152 | 156 |
| 2014 | 154 | 186 |
| 2015 | 116 | 139 |
| 2016 | 115 | 124 |
| 2017 | 110 | 101 |
| 2018 | 83 | 95 |
| 2019 | 62 | 89 |
| 2020 | 60 | 80 |
| 2021 | 48 | 58 |
| 2022 | 28 | 63 |
| 2023 | 27 | 50 |
| 2024 | 26 | 47 |
| 2025 | 20 | 37 |
| 2026 | 6 | 17 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- HCL-binding compositions for and methods of treating acid-base disorders2 Jun 2026US 12,642,815 B2Renibus Therapeutics, Inc.
- Choline bolus compositions for ruminants31 Mar 2026US 12,589,084 B2Alberta Veterinary Laboratories Ltd.
- Use of collagen hydrolysate in prevention and/or treatment of food craving31 Mar 2026US 12,589,131 B2Rousselot B.V.
- Extended use zirconium silicate compositions and methods of use thereof24 Mar 2026US 12,582,673 B2Zs Pharma, Inc.
- Use of triazole compound as ghrelin receptor agonist10 Mar 2026US 12,570,617 B2Kyungpook National University Industry-Academic Cooperation Foundation
- Treatment of hypoparathyroidism using triphenyl calcilytic compounds1 Oct 2026US 2026/0294857 A1Calcilytix Therapeutics, Inc.
- Coated sorbent materials for the removal of ammonium and associated method of use10 Sep 2026US 2026/0263509 A1HemoCleanse Technologies LLC
- Necrosis inhibitor30 Jul 2026US 2026/0216141 A1Linkgevity Limited
- Compositions for use in the prophylactic treatment of hypocalcemia in a ruminant animal23 Jul 2026US 2026/0207659 A1Vilofoss A/S
- C5ar antagonists23 Jul 2026US 2026/0209179 A1ChemoCentryx, Inc.
Most cited
By later US patents
- Devices and methods for the restoration of a spinal disc248US 7,004,945 B2SpineWave, Inc. · 2006
- Use of dipeptidyl peptidase IV effectors for lowering the blood glucose level in mammals233US 6,303,661 B1Probiodrug AG · 2001
- Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same222US 5,359,030 AProtein Delivery, Inc. · 1994
- Generation of high titers of recombinant AAV vectors215US 5,658,776 ATargeted Genetics Corporation · 1997
- Albumin fusion proteins comprising GLP-1 polypeptides198US 7,141,547 B2Human Genome Sciences, Inc. · 2006